Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis [3]

Annals of the Rheumatic Diseases

Volumn 66, Issue 8, 2007, Pages 1124-1125

  Lo Monaco, Andrea ^a,c   Gulinelli, Sara ^a   Castellino, Gabriella ^a   Solini, Anna ^b   Ferrari, Davide ^a   La Corte, Renato ^a   Trotta, Francesco ^a   Di Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CLOPIDOGREL; IMMUNOMODULATING AGENT; INTERLEUKIN 6; P2 PROTEIN ANTAGONIST; PURINE P2 RECEPTOR; UNCLASSIFIED DRUG;

CALCIUM HOMEOSTASIS; CYTOKINE RELEASE; DRUG MECHANISM; FIBROBLAST; HUMAN; LETTER; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADENOSINE TRIPHOSPHATE; CASE-CONTROL STUDIES; CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERLEUKIN-6; RECEPTORS, PURINERGIC P2; SCLERODERMA, SYSTEMIC;

EID: 34547223531     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.065078     Document Type: Letter

References (9)

1. Steen VD, Medsger TA Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990;16:1-10.
2. LeRoy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996;22:675-94.
3. Strehlow D, Korn JH. Biology of the scleroderma fibroblast. Curr Opin Rheumatol 1998;10:572-8.
4. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 1999;112:297-305.
5. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004;10:821-7.
6. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
7. Solini A, Chiozzi P, Morelli A, Adinolfi E, Rizzo E, Baricordi O, et al. Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes. Arterioscler Thromb Vasc Biol 2004;24:1240-5.
8. Gochet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2006;46:277-300.
9. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Jimenez-Quevedo P, et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 2006;55:780-4.